[1] 中华医学会儿科学分会内分泌遗传代谢学组,中华预防医学会出生缺陷预防与控制专业委员会新生儿筛查学组,高苯丙氨酸血症的诊治共识[J].中华儿科杂志,2014,52(6):420-425. [2] 叶军,顾学范.高苯丙氨酸血症诊治共识解读[J].中华儿科杂志,2014,52(6):430-432. [3] 陈挺,赵正言,蒋萍萍,等.高苯丙氨酸血症表型与基因型研究进展[J].浙江大学学报:医学版,2018,47(3):219-226. [4] Singh RH,Rohr F,Frazier D,et al.Recommendations for the nutrition management of phenylalanine bydroxylase deficiency[J].Genet Med,2014,16(2):121-131. [5] 中华人民共和国卫生部.苯丙酮尿症和先天性甲状腺功能减低症诊治技术规范[卫妇社发(96)号][S].2011. [6] 朱玲,杨建平,董勤,等.97例苯丙酮尿症患儿的治疗效果[J].中华围产医学杂志,2015,18(3):200-203. [7] Rohde C,von Teeffelen-Heithoff A,Thiele AG,et al.PKU patients on a relaxed diet may be at risk for micronutrient deficiencies[J].Eur J Clin Nutr,2014,68(1):119-124. [8] van Wegberg AMJ,MacDonald A,Ahring K,et al.The complete European guidelines on phenylketonuria:diagnosis and treatment[J].Orphanet J Rare Dis,2017,12(1):162. [9] 毛新梅,田海燕,马晓燕.宁夏106例苯丙酮尿症患儿低苯丙氨酸饮食控制疗效评估[J].宁夏医科大学学报,2016,38(8):897-900. [10] 李松,孙巧玲,周怡,等.安徽省174例苯丙酮尿症患儿智力发育及其影响因素分析[J].中华疾病控制杂志,2015,19(5):466-469. [11] van Spronsen FJ,van Wegberg AM,Ahring K,et al.Key Eu ropean guidelines for the diagnosis and management of patients with phenylketonuria[J].Lancet Diabetes Endo,2017,5(9):743-756. [12] Jahja R,Huijbregts SC,de Sonneville LM,et al.Neurocognitive evidence for revision of treatment targets and guidelines for phenylketonuria[J].J Pediatr,2014,164(4):895-899. |